சிலிக்கான் வாழ்க்கை அறிவியல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Aurobindo Pharma announced that it received the approval of the Hon ble National Company Law Tribunal, Hyderabad bench vide order dated 30 March 2021 for the modified scheme of amalgamation of wholly owned subsidiaries of Aurobindo Pharma viz., APL Healthcare and APL Research Centre and Aurozymes and Curepro Parenterals and Hyacinths Pharma and Silicon Life Sciences with Aurobindo Pharma.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continu ....

Andhra Pradesh , Curepro Parenterals , Aurobindo Pharma , Honble National Company Law Tribunal , Silicon Life Sciences , Research Centre , Hon Ble National Company Law Tribunal , Hyacinths Pharma , Capital Market , ஆந்திரா பிரதேஷ் , அரவிந்தோ பார்மா , சிலிக்கான் வாழ்க்கை அறிவியல் , ஆராய்ச்சி மையம் , க .ரவ ப்ளே தேசிய நிறுவனம் சட்டம் தீர்ப்பாயம் , மூலதனம் சந்தை ,